Perfect
PERFormance, Effectiveness and Cost of Treatment Episodes
The PERFECT project aims to develop methods for register-based measurement of the cost-effectiveness of treatment and to create a comparative database that allows the treatments given and their costs and effectiveness to be compared between hospitals, hospital districts, regions and population groups. The project:
Produces comparative information on treatments and their costs and effectiveness for treatment monitoring and development.
Creates indicators and models for monitoring the content, quality and cost-effectiveness of treatment episodes in specialised medical care.
Assesses factors that influence cost-effectiveness.
Develops methods for the register-based measurement of cost-effectiveness, and comes up with proposals concerning the data content of national level registers in order to improve the continuous monitoring of cost-effectiveness.
Develops an approach and methodology that can be subsequently applied to other disease groups as well.
Compares cost-effectiveness at an international level.
The focus will first be on selected disease groups with sufficient significance in terms of costs and disease burden and where specialised medical care plays a key role: stroke, hip fracture, low-birth-weight infants, breast cancer, schizophrenia, acute myocardial infarction, and hip and knee replacements.
Each sub-project has its own expert group, and each university hospital district is responsible for one sub-project.
PERFECT is a joint project by the Social Insurance Institution of Finland, STAKES and university hospital districts that will run 2004-2007. The project forms part the Academy of Finland's Research Programme on Health Services Research is also funded by Finnish Funding Agency of Tecnology and Innovation (FinnWELL - Future Health care Technology Programme) and SITRA (the Finnish Innovation Fund). The project forms also the Finnish port of EUPHORIC (EU Public outcome Research and indicators collection) http://www.euphoric-project.eu/ funded by the European comission.